About Eysys Pharmaceuticals
Eysys Pharmaceuticals is a Healthcare company based in Chennai (India). Pharmaceutical solutions and healthcare products focused on quality medical management in India. The company has 58 employees. Its Indian entity Eysys Pharmaceutical Private Limited reported revenue of ₹127 Cr. Eysys Pharmaceuticals offers products and services including ATHENA and OSTARA. Its focus areas include Pharmaceuticals, Over-the-counter Drugs, Pain Management and Prescription Drugs.
Company details
Eysys Pharmaceuticals is recognized for its diverse portfolio of over 100 healthcare solutions, which are developed with a focus on quality and affordability. The company was established in Kerala in 2014 as ISIS Healthcare and is now headquartered in Chennai. It is supported by an extensive network of over 400 channel partners and 1,000 medical experts, ensuring reliable delivery of pharmaceutical products across various therapeutic areas. Efforts are directed towards maintaining ethical standards and expanding access to critical medicines nationwide, with a commitment to serving users through innovative approaches.
- Headquarters Chennai, India
- Employees 58
- SectorsHealthcare
- Website eysys.co.in
- Legal Name Eysys Pharmaceutical Pvt Ltd
- Date of Incorporation 07 Aug, 2019
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹127 Cr
FY 2024 · +40% YoY
- Net Profit₹7.58 Cr
FY 2024 · 6% margin
- EBITDA₹10.63 Cr
FY 2024 · 8% margin
- Employee Count58
Associated legal entities of Eysys Pharmaceuticals
Eysys Pharmaceuticals operates through Eysys Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eysys Pharmaceutical Private Limited CIN U24230TN2019PTC130992 | Active | 07 Aug 2019 | Chennai, Tamil Nadu | ₹127 Cr | 58 | 3 | View details |
Products & Services of Eysys Pharmaceuticals
Eysys Pharmaceuticals offers a comprehensive portfolio of products and services, including ATHENA and OSTARA.
A pharmaceutical product is provided for cardia and diabetic management within the company's portfolio.
Products are offered for gastro, respiratory, and pain management as part of the company's healthcare solutions.
Board of directors of Eysys Pharmaceutical Private Limited (Eysys Pharmaceuticals)
Eysys Pharmaceutical Private Limited is the primary company behind Eysys Pharmaceuticals. The board of Eysys Pharmaceutical Private Limited currently have 3 directors; the longest-serving is Raveendran Ratheesh, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raveendran Ratheesh DIN 08114517 | Managing Director | 07 Aug 2019 | 7 yrs 3 mo | Eysys Pharmaceutical Private Limited |
| Mani Deepakkumar DIN 08532418 | Director | 07 Aug 2019 | 7 yrs 3 mo | Eysys Pharmaceutical Private Limited |
| Manian Jayakrishnan DIN 08532419 | Director | 07 Aug 2019 | 7 yrs 3 mo | Eysys Pharmaceutical Private Limited |
Financials of Eysys Pharmaceuticals
Figures of Eysys Pharmaceutical Private Limited, the primary company behind Eysys Pharmaceuticals, for FY 2024. Revenue was ₹127 Cr (+40% year on year). Net profit was ₹7.58 Cr (6% margin). EBITDA was ₹10.63 Cr (8% margin). Revenue has grown at a compounded annual rate of +51% over three years.
- ₹127 CrRevenue · FY 2024 · +40% YoY
- ₹7.58 CrNet profit · 6% margin
- ₹10.63 CrEBITDA · 8% margin
- ₹10 LakhPaid-up capital
- 58Employees (provident fund records)
- +51%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Eysys Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Eysys Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eysys Pharmaceuticals
Eysys Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Eysys Pharmaceuticals has 58 employees.
The primary company behind Eysys Pharmaceuticals, Eysys Pharmaceutical Private Limited, reported revenue of ₹127 Cr for FY 2024, up 40% year on year.
Eysys Pharmaceuticals is recognized for its diverse portfolio of over 100 healthcare solutions, which are developed with a focus on quality and affordability. The company was established in Kerala in 2014 as ISIS Healthcare and is now headquartered in Chennai. It is supported by an extensive network of over 400 channel partners and 1,000 medical experts, ensuring reliable delivery of pharmaceutical products across various therapeutic areas. Efforts are directed towards maintaining ethical standards and expanding access to critical medicines nationwide, with a commitment to serving users through innovative approaches.
Eysys Pharmaceuticals offers ATHENA and OSTARA.
Eysys Pharmaceuticals operates through Eysys Pharmaceutical Private Limited.
The legal entities of Eysys Pharmaceuticals currently have 3 directors, including Raveendran Ratheesh, Mani Deepakkumar, Manian Jayakrishnan.